Literature DB >> 24478333

Sildenafil improves exercise hemodynamics in Fontan patients.

Alexander Van De Bruaene1, Andre La Gerche, Guido Claessen, Pieter De Meester, Sarah Devroe, Hilde Gillijns, Jan Bogaert, Piet Claus, Hein Heidbuchel, Marc Gewillig, Werner Budts.   

Abstract

BACKGROUND: Patients with Fontan circulation have reduced exercise capacity. The absence of a presystemic pump may limit flow through the pulmonary circulation, restricting ventricular filling and cardiac output. We evaluated exercise hemodynamics and the effect of sildenafil on exercise hemodynamics in Fontan patients. METHODS AND
RESULTS: Ten Fontan patients (6 men, 20±4 years) underwent cardiac magnetic resonance imaging at rest and during supine bicycle exercise before and after sildenafil. Systemic ventricular volumes were obtained at rest and during low- (34±15 W), moderate- (69±29 W), and high-intensity (97±36 W) exercise using an ungated, free-breathing cardiac magnetic resonance sequence and analyzed correcting for cardiac phase and respiratory translation. Radial and pulmonary artery pressures and cGMP were measured. Before sildenafil, cardiac index increased throughout exercise (4.0±0.9, 5.9±1.1, 7.0±1.6, 7.4±1.7 L/(min·m(2)); P<0.0001) with 106±49% increase in heart rate. Stroke volume index (P=0.015) and end-diastolic volume index (P=0.001) decreased during exercise. End-systolic volume index remained unchanged (P=0.8). Total pulmonary resistance index (P=0.005) increased, whereas systemic vascular resistance index decreased during exercise (P<0.0001). Sildenafil increased cardiac index (P<0.0001) and stroke volume index (P=0.003), especially at high-intensity exercise (interaction P=0.004 and P=0.003, respectively). Systemic vascular resistance index was reduced (P<0.0001-interaction P=0.1), whereas total pulmonary resistance index was reduced at rest and reduced further during exercise (P=0.008-interaction P=0.029). cGMP remained unchanged before sildenafil (P=0.9), whereas it increased significantly after sildenafil (P=0.019).
CONCLUSIONS: In Fontan patients, sildenafil improved cardiac index during exercise with a decrease in total pulmonary resistance index and an increase in stroke volume index. This implies that pulmonary vasculature represents a physiological limitation, which can be attenuated by sildenafil, the clinical significance of which warrants further study.

Entities:  

Keywords:  Fontan procedure; cyclic GMP; exercise; pulmonary circulation; sildenafil

Mesh:

Substances:

Year:  2014        PMID: 24478333     DOI: 10.1161/CIRCIMAGING.113.001243

Source DB:  PubMed          Journal:  Circ Cardiovasc Imaging        ISSN: 1941-9651            Impact factor:   7.792


  31 in total

1.  Response by Goldberg et al to Letter Regarding Article, "Results of the FUEL Trial".

Authors:  David J Goldberg; Stephen M Paridon
Journal:  Circulation       Date:  2020-07-27       Impact factor: 29.690

2.  Computational modeling of pathophysiologic responses to exercise in Fontan patients.

Authors:  Ethan Kung; James C Perry; Christopher Davis; Francesco Migliavacca; Giancarlo Pennati; Alessandro Giardini; Tain-Yen Hsia; Alison Marsden
Journal:  Ann Biomed Eng       Date:  2014-09-27       Impact factor: 3.934

Review 3.  Management of acute heart failure in adult patients with congenital heart disease.

Authors:  Alexander Van De Bruaene; Lukas Meier; Walter Droogne; Pieter De Meester; Els Troost; Marc Gewillig; Werner Budts
Journal:  Heart Fail Rev       Date:  2018-01       Impact factor: 4.214

Review 4.  Treatment of heart failure in adult congenital heart disease: a position paper of the Working Group of Grown-Up Congenital Heart Disease and the Heart Failure Association of the European Society of Cardiology.

Authors:  Werner Budts; Jolien Roos-Hesselink; Tanja Rädle-Hurst; Andreas Eicken; Theresa A McDonagh; Ekaterini Lambrinou; Maria G Crespo-Leiro; Fiona Walker; Alexandra A Frogoudaki
Journal:  Eur Heart J       Date:  2016-01-18       Impact factor: 29.983

5.  Efficacy of Sports Club Activities on Exercise Tolerance Among Japanese Middle and High School Children and Adolescents After Fontan Procedure.

Authors:  Yoshihiko Kodama; Kyoko Koga; Ayako Kuraoka; Yuichi Ishikawa; Makoto Nakamura; Koichi Sagawa; Shiro Ishikawa
Journal:  Pediatr Cardiol       Date:  2018-05-21       Impact factor: 1.655

Review 6.  Design and rationale of the Fontan Udenafil Exercise Longitudinal (FUEL) trial.

Authors:  David J Goldberg; Victor Zak; Bryan H Goldstein; Brian W McCrindle; Shaji C Menon; Kurt R Schumacher; R Mark Payne; Jonathan Rhodes; Kimberly E McHugh; Daniel J Penny; Felicia Trachtenberg; Michelle S Hamstra; Marc E Richmond; Peter C Frommelt; Matthew D Files; James L Yeager; Victoria L Pemberton; Mario P Stylianou; Gail D Pearson; Stephen M Paridon
Journal:  Am Heart J       Date:  2018-04-03       Impact factor: 4.749

7.  Results of the FUEL Trial.

Authors:  David J Goldberg; Victor Zak; Bryan H Goldstein; Kurt R Schumacher; Jonathan Rhodes; Daniel J Penny; Christopher J Petit; Salil Ginde; Shaji C Menon; Seong-Ho Kim; Gi Beom Kim; Todd T Nowlen; Michael V DiMaria; Benjamin P Frischhertz; Jonathan B Wagner; Kimberly E McHugh; Brian W McCrindle; Amanda J Shillingford; Arash A Sabati; Anji T Yetman; Anitha S John; Marc E Richmond; Matthew D Files; R Mark Payne; Andrew S Mackie; Christopher K Davis; Shabana Shahanavaz; Kevin D Hill; Ruchira Garg; Jeffrey P Jacobs; Michelle S Hamstra; Stacy Woyciechowski; Kathleen A Rathge; Michael G McBride; Peter C Frommelt; Mark W Russell; Elaine M Urbina; James L Yeager; Victoria L Pemberton; Mario P Stylianou; Gail D Pearson; Stephen M Paridon
Journal:  Circulation       Date:  2019-11-17       Impact factor: 29.690

Review 8.  Pulmonary Hypertension in Children.

Authors:  Dunbar Ivy
Journal:  Cardiol Clin       Date:  2016-08       Impact factor: 2.213

9.  Effect of Inhaled Nitric Oxide on Blood Flow Dynamics in Patients After the Fontan Procedure Using Cardiovascular Magnetic Resonance Flow Measurements.

Authors:  Heiner Latus; Bettina Gerstner; Gunter Kerst; Axel Moysich; Kerstin Gummel; Christian Apitz; Juergen Bauer; Dietmar Schranz
Journal:  Pediatr Cardiol       Date:  2015-11-07       Impact factor: 1.655

10.  Results of a phase I/II multi-center investigation of udenafil in adolescents after fontan palliation.

Authors:  David J Goldberg; Victor Zak; Bryan H Goldstein; Shan Chen; Michelle S Hamstra; Elizabeth A Radojewski; Eileen Maunsell; Seema Mital; Shaji C Menon; Kurt R Schumacher; R Mark Payne; Mario Stylianou; Jonathan R Kaltman; Tina M deVries; James L Yeager; Stephen M Paridon
Journal:  Am Heart J       Date:  2017-03-06       Impact factor: 4.749

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.